Your browser doesn't support javascript.
loading
MUC1-C Activates the NuRD Complex to Drive Dedifferentiation of Triple-Negative Breast Cancer Cells.
Hata, Tsuyoshi; Rajabi, Hasan; Takahashi, Hidekazu; Yasumizu, Yota; Li, Wei; Jin, Caining; Long, Mark D; Hu, Qiang; Liu, Song; Fushimi, Atsushi; Yamashita, Nami; Kui, Ling; Hong, Deli; Yamamoto, Masaaki; Miyo, Masaaki; Hiraki, Masayuki; Maeda, Takahiro; Suzuki, Yozo; Samur, Mehmet K; Kufe, Donald.
Afiliação
  • Hata T; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Rajabi H; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Takahashi H; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Yasumizu Y; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Li W; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Jin C; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Long MD; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Hu Q; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Liu S; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Fushimi A; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Yamashita N; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Kui L; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Hong D; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Yamamoto M; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Miyo M; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Hiraki M; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Maeda T; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Suzuki Y; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Samur MK; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Kufe D; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. donald_kufe@dfci.harvard.edu.
Cancer Res ; 79(22): 5711-5722, 2019 11 15.
Article em En | MEDLINE | ID: mdl-31519689
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Diferenciação Celular / Mucina-1 / Complexo Mi-2 de Remodelação de Nucleossomo e Desacetilase / Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Res Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Diferenciação Celular / Mucina-1 / Complexo Mi-2 de Remodelação de Nucleossomo e Desacetilase / Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Res Ano de publicação: 2019 Tipo de documento: Article